Industry / United States
New Code Increases Restrictions On Drugmakers' Promotional Activities
July 2008 | Industry NewsThe Pharmaceutical Research & Manufacturers of America's (PhRMA) new voluntary code of conduct has increased the restrictions on drug companies' promotional activities.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
